I agree that this site is using cookies. You can find further informations here.
X
Hotta, Katsuyuki
278  results:
Search for persons X
?
1

A Prompt Diagnosis and Treatment of a Case of Nuclear Prote..:

Matsuura, Hiroaki ; Makimoto, Go ; Oda, Naohiro...
Internal Medicine.  , 2024
Link: https://doi.org/10.2169/..
 
?
2

Concomitant osimertinib and antituberculosis therapy in an ..:

Matsuura, Hiroaki ; Higo, Hisao ; Kuribayashi, Tadahiro...
Thoracic Cancer.  15 (2024)  17 - p. 1390-1394 , 2024
Link: https://doi.org/10.1111/..
 
?
3

Impacts of probiotics on the efficacies of immune checkpoin..:

Morita, Ayako ; Ichihara, Eiki ; Inoue, Koji...
International Journal of Cancer.  154 (2024)  9 - p. 1607-1615 , 2024
Link: https://doi.org/10.1002/..
 
?
4

Severe Cytokine Release Syndrome and Immune Effector Cell-a..:

Tanaka, Takaaki ; Taoka, Masataka ; Makimoto, Go...
Internal Medicine.  63 (2024)  9 - p. 1261-1267 , 2024
Link: https://doi.org/10.2169/..
 
?
5

Factors Associated with Differences in Physicians' Attitude..:

Sakamoto, Yoko ; Mitsuhashi, Toshiharu ; Hotta, Katsuyuki
Palliative Medicine Reports.  5 (2024)  1 - p. 206-214 , 2024
Link: https://doi.org/10.1089/..
 
?
6

Clinical characteristics of patients treated with immune ch..:

Kuribayashi, Tadahiro ; Ohashi, Kadoaki ; Nishii, Kazuya...
Journal of Cancer Research and Clinical Oncology.  150 (2024)  2 - p. , 2024
Link: https://doi.org/10.1007/..
 
?
7

Fulminant Myocarditis for Non-small-cell Carcinoma of the L..:

Nishimura, Tomoka ; Ninomiya, Kiichiro ; Nakashima, Mitsutaka...
Internal Medicine.  62 (2023)  9 - p. 1319-1322 , 2023
Link: https://doi.org/10.2169/..
 
?
8

A randomized phase II study of afatinib alone or combined w..:

Ninomiya, Takashi ; Ishikawa, Nobuhisa ; Kozuki, Toshiyuki...
Lung Cancer.  184 (2023)  - p. 107349 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Randomized phase II study of daily versus alternate-day adm..:

Yamamoto, Hiromasa ; Soh, Junichi ; Okumura, Norihito...
PLOS ONE.  18 (2023)  5 - p. e0285273 , 2023
Link: https://doi.org/10.1371/..
 
?
10

First-line nivolumab plus ipilimumab in metastatic non-smal..:

Nishio, Makoto ; Ohe, Yuichiro ; Ikeda, Satoshi...
International Journal of Clinical Oncology.  28 (2023)  10 - p. 1354-1368 , 2023
Link: https://doi.org/10.1007/..
 
?
11

Efficacy of immune checkpoint inhibitor monotherapy in elde..:

Kubo, Toshio ; Ichihara, Eiki ; Harada, Daijiro...
Respiratory Investigation.  61 (2023)  5 - p. 643-650 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Correction to: First-line nivolumab plus ipilimumab in meta..:

Nishio, Makoto ; Ohe, Yuichiro ; Ikeda, Satoshi...
International Journal of Clinical Oncology.  28 (2023)  10 - p. 1369-1370 , 2023
Link: https://doi.org/10.1007/..
 
?
13

Durvalumab ± Tremelimumab + Platinum-Etoposide in Extensive..:

Paz-Ares, Luis ; Garassino, Marina Chiara ; Chen, Yuanbin...
Clinical Cancer Research.  30 (2023)  4 - p. 824-835 , 2023
Link: https://doi.org/10.1158/..
 
?
14

Efficacy of gilteritinib in comparison with alectinib for t..:

Ando, Chihiro ; Ichihara, Eiki ; Nishi, Tatsuya...
Cancer Science.  114 (2023)  11 - p. 4343-4354 , 2023
Link: https://doi.org/10.1111/..
 
?
15

PD-1 blockade augments CD8+ T cell dependent antitumor immu..:

Nakasuka, Takamasa ; Ohashi, Kadoaki ; Nishii, Kazuya...
Lung Cancer.  178 (2023)  - p. 1-10 , 2023
Link: https://doi.org/10.1016/..
 
1-15